Dore GJ - Search Results

1

Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study.

Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Dore GJ, Grebely J; InC3 Study Group. Hajarizadeh B, et al. Among authors: dore gj. PLoS One. 2015 Apr 2;10(4):e0122232. doi: 10.1371/journal.pone.0122232. eCollection 2015. PLoS One. 2015. PMID: 25837807 Free PMC article.

2

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

Freeman AJ, Dore GJ, Law MG, Thorpe M, Von Overbeck J, Lloyd AR, Marinos G, Kaldor JM. Freeman AJ, et al. Among authors: dore gj. Hepatology. 2001 Oct;34(4 Pt 1):809-16. doi: 10.1053/jhep.2001.27831. Hepatology. 2001. PMID: 11584380

3

Risk factors leading to Cryptosporidium infection in men who have sex with men.

Hellard M, Hocking J, Willis J, Dore G, Fairley C. Hellard M, et al. Sex Transm Infect. 2003 Oct;79(5):412-4. doi: 10.1136/sti.79.5.412. Sex Transm Infect. 2003. PMID: 14573839 Free PMC article.

4

HIV and hepatitis C coinfection within the CAESAR study.

Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ. Amin J, et al. Among authors: dore gj. HIV Med. 2004 May;5(3):174-9. doi: 10.1111/j.1468-1293.2004.00207.x. HIV Med. 2004. PMID: 15139984 Free article. Clinical Trial.

5

Clearance of hepatitis C virus after newly acquired infection in injection drug users.

Jauncey M, Micallef JM, Gilmour S, Amin J, White PA, Rawlinson W, Kaldor JM, van Beek I, Dore GJ. Jauncey M, et al. Among authors: dore gj. J Infect Dis. 2004 Oct 1;190(7):1270-4. doi: 10.1086/423943. Epub 2004 Aug 18. J Infect Dis. 2004. PMID: 15346337

6

Hepatitis C virus incidence among injecting drug users on opioid replacement therapy.

Hallinan R, Byrne A, Amin J, Dore GJ. Hallinan R, et al. Among authors: dore gj. Aust N Z J Public Health. 2004 Dec;28(6):576-8. doi: 10.1111/j.1467-842x.2004.tb00050.x. Aust N Z J Public Health. 2004. PMID: 15707209 Free article.

7

Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.

Hallinan R, Byrne A, Amin J, Dore GJ. Hallinan R, et al. Among authors: dore gj. J Gastroenterol Hepatol. 2005 Jul;20(7):1082-6. doi: 10.1111/j.1440-1746.2005.03882.x. J Gastroenterol Hepatol. 2005. PMID: 15955218

8

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.

Micallef JM, Kaldor JM, Dore GJ. Micallef JM, et al. Among authors: dore gj. J Viral Hepat. 2006 Jan;13(1):34-41. doi: 10.1111/j.1365-2893.2005.00651.x. J Viral Hepat. 2006. PMID: 16364080 Review.

9

Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study.

Amin J, Dore GJ, O'Connell DL, Bartlett M, Tracey E, Kaldor JM, Law MG. Amin J, et al. Among authors: dore gj. J Hepatol. 2006 Aug;45(2):197-203. doi: 10.1016/j.jhep.2006.02.014. Epub 2006 Mar 31. J Hepatol. 2006. PMID: 16684579

10

Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users.

Amin J, Law MG, Micallef J, Jauncey M, Van Beek I, Kaldor JM, Dore GJ. Amin J, et al. Among authors: dore gj. Epidemiol Infect. 2007 Jan;135(1):144-50. doi: 10.1017/S0950268806006388. Epub 2006 May 17. Epidemiol Infect. 2007. PMID: 16707030 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

518 results

Search Page